Shuangxi Li

2.1k total citations · 1 hit paper
96 papers, 1.4k citations indexed

About

Shuangxi Li is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology. According to data from OpenAlex, Shuangxi Li has authored 96 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 34 papers in Surgery and 30 papers in Gastroenterology. Recurrent topics in Shuangxi Li's work include Gastric Cancer Management and Outcomes (50 papers), Metastasis and carcinoma case studies (31 papers) and Gastrointestinal Tumor Research and Treatment (30 papers). Shuangxi Li is often cited by papers focused on Gastric Cancer Management and Outcomes (50 papers), Metastasis and carcinoma case studies (31 papers) and Gastrointestinal Tumor Research and Treatment (30 papers). Shuangxi Li collaborates with scholars based in China, Ethiopia and United States. Shuangxi Li's co-authors include Ziyu Li, Jiafu Ji, Fei Shan, Lianhai Zhang, Yongning Jia, Jin Jiang, Zhaode Bu, Yinkui Wang, Xiaojiang Wu and Xianglong Zong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shuangxi Li

89 papers receiving 1.4k citations

Hit Papers

The effectiveness and safety of therapies for hepatocellu... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuangxi Li China 22 627 386 367 283 240 96 1.4k
Hongqing Xi China 24 631 1.0× 763 2.0× 416 1.1× 543 1.9× 266 1.1× 81 1.9k
Wenjun Xiong China 18 291 0.5× 396 1.0× 192 0.5× 295 1.0× 75 0.3× 80 1.0k
Hirofumi Sonoda Japan 15 139 0.2× 690 1.8× 277 0.8× 333 1.2× 41 0.2× 102 1.2k
Lizong Shen China 26 415 0.7× 1.0k 2.6× 429 1.2× 670 2.4× 65 0.3× 52 1.9k
Katsutoshi Shoda Japan 20 413 0.7× 739 1.9× 369 1.0× 400 1.4× 79 0.3× 118 1.5k
Tao‐Wei Ke Taiwan 22 202 0.3× 523 1.4× 358 1.0× 741 2.6× 87 0.4× 90 1.4k
Kuo‐Hung Huang Taiwan 29 935 1.5× 1.1k 2.8× 642 1.7× 479 1.7× 347 1.4× 75 2.4k
Kiyoshi Asada Japan 19 252 0.4× 696 1.8× 355 1.0× 121 0.4× 37 0.2× 38 1.3k
Ziwei Wang China 16 168 0.3× 471 1.2× 133 0.4× 221 0.8× 43 0.2× 51 932

Countries citing papers authored by Shuangxi Li

Since Specialization
Citations

This map shows the geographic impact of Shuangxi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangxi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangxi Li more than expected).

Fields of papers citing papers by Shuangxi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangxi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangxi Li. The network helps show where Shuangxi Li may publish in the future.

Co-authorship network of co-authors of Shuangxi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangxi Li. A scholar is included among the top collaborators of Shuangxi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangxi Li. Shuangxi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2025). Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests. European Journal of Surgical Oncology. 51(8). 109752–109752.
3.
Chen, Xingming, et al.. (2025). Experimental approaches to the function of tumor-associated lymphatic vessels. PubMed. 6(1). 3–4.
6.
Yang, Zisheng, et al.. (2025). The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior vena cave and/or right atrium: a systematic review and single-arm meta-analysis. Expert Review of Anticancer Therapy. 25(5). 561–570. 23 indexed citations breakdown →
7.
Li, Shuangxi, et al.. (2024). Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study. Biotechnology and Applied Biochemistry. 71(6). 1281–1292. 2 indexed citations
8.
Li, Yu, et al.. (2024). RACK1 and IRE1 participate in the translational quality control of amyloid precursor protein in Drosophila models of Alzheimer’s disease. Journal of Biological Chemistry. 300(3). 105719–105719. 3 indexed citations
9.
Geng, Ji, Shuangxi Li, Yu Li, et al.. (2024). Stalled translation by mitochondrial stress upregulates a CNOT4-ZNF598 ribosomal quality control pathway important for tissue homeostasis. Nature Communications. 15(1). 1637–1637. 9 indexed citations
10.
Li, Yu, et al.. (2023). The IRE1/Xbp1 axis restores ER and tissue homeostasis perturbed by excess Notch in Drosophila. Developmental Biology. 507. 11–19. 2 indexed citations
11.
Shan, Fei, Shuangxi Li, Yongning Jia, et al.. (2022). The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer. Frontiers in Oncology. 12. 956706–956706. 1 indexed citations
12.
Davis, Zoe H., Laura Mediani, Jonathan Vinet, et al.. (2021). Protein products of nonstop mRNA disrupt nucleolar homeostasis. Cell Stress and Chaperones. 26(3). 549–561. 5 indexed citations
13.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2021). Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer. European Journal of Surgical Oncology. 47(8). 2023–2030. 11 indexed citations
14.
Liu, Zining, Yinkui Wang, Fei Shan, et al.. (2021). Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved. Frontiers in Oncology. 11. 775166–775166. 3 indexed citations
15.
Shan, Fei, Xiao‐Long Li, Ziyu Li, et al.. (2020). Short- and Long-Term Outcomes after Laparoscopic Versus Open Gastrectomy for Elderly Gastric Cancer Patients: A Systematic Review and Meta-Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 30(7). 713–722. 3 indexed citations
16.
Li, Shuangxi, et al.. (2020). Gilgamesh (Gish)/CK1γ regulates tissue homeostasis and aging in adult Drosophila midgut. The Journal of Cell Biology. 219(4). 10 indexed citations
17.
Li, Shuangxi, et al.. (2019). Clinical study of neurology nursing on cerebral apoplexy rehabilitation. Translational Neuroscience. 10(1). 164–167. 6 indexed citations
19.
Miao, Rulin, Ziyu Li, Yinkui Wang, et al.. (2016). Usage of mechanical stapler in digestive tract reconstruction of laparoscopic total gastrectomy. 36(9). 972. 1 indexed citations
20.
Li, Shuangxi. (2010). Study on the Effectiveness of Rotavirus Vaccine for Oral Use to Prevent Diarrhea in the Community. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026